|
|
|
|
||
Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAghttps://investor.arbutusbio.com/news-releases/news-release-details/arbutus-announces-ab-729-90-mg-single-dose-week-12-data-chronic |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
34947 | Re: Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAg | spaddy | 1 | 9/16/2020 10:31:14 AM |